Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.
City of Hope Medical Center
City of Hope Medical Center
Celldex Therapeutics
Seagen Inc.
Merck Sharp & Dohme LLC
University of Washington
Ohio State University Comprehensive Cancer Center